Work

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers.

Year: 2009

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.1063.1063

Authors: Khalid Abd-Elaziz, Pieter W. Kamphuisen, Christophe Lyssens, Mariska Reuvers, Izaak den Daas, Femke Van Bockstaele, Kristof Vercruysse, Hans Ulrichts, Judith Baumeister, Patricia Crabbe, Veerle Compernolle, Josefin-Beate Holz

Institutions: Xendo (Netherlands), Amsterdam UMC Location University of Amsterdam, Ablynx (Belgium)

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980249212

FWCI: 0.413

Cites:

Cited by: 6

Related to: 10